Agfa launches SYNAPS synthetic paper protected against bacteria and viruses

Today, Agfa announces the market launch of its SYNAPS Xerographic Matt (XM) synthetic paper that includes an agent which antagonizes the settlement and growth of bacteria and viruses on its surface.

The agent remains active for the entire life of the synthetic paper and protects also print areas that are covered with toner ink. Its efficiency up to 99,99% has been proven through independent ISO 20743 and ISO 18184 tests.

This new type of SYNAPS XM replaces the existing XM product range while fully preserving its excellent print quality, antistatic process behavior and universal printer compatibility.

For full product information and list of distributors, please visit www.agfa.com/synaps

About SYNAPS

SYNAPS is a polyester-based print media developed, manufactured and marketed by Agfa. It comes in two versions based on distinct print technology for offset and electro-ink (SYNAPS OM) and xerography or dry toner (SYNAPS XM). Both OM and XM products are available in a variety of thicknesses and OM includes also a self-adhesive type. The use of SYNAPS is driven by applications that require indoor or outdoor durability without the need for lamination, such as tags, signage, labels, posters, menu cards.

About Agfa

The Agfa-Gevaert Group is a leading company in imaging technology and IT solutions with over 150 years of experience. The Group holds four divisions: Radiology Solutions, HealthCare IT, Digital Print & Chemicals and Offset Solutions. They develop, manufacture and market analogue and digital systems for the healthcare sector, for specific industrial applications and for the printing industry. In 2020, the Group realized a turnover of 1.709 million Euro.

SYNAPS, Agfa and the Agfa rhombus are trademarks of Agfa-Gevaert N.V., Belgium, or its affiliates. Other brands mentioned belong to respective owners.

Contact

Werner Vandevelde, Marketing Manager
Septestraat 27   2640 Mortsel – Belgium
+32 (0) 3 444 8004         werner.vandevelde@agfa.com